BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8057000)

  • 21. Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study.
    Arranz FJ; Ros S
    J Affect Disord; 1997 Dec; 46(3):285-91. PubMed ID: 9547126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
    Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
    Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of mixed affective disorders in general practice: a comparison of trazodone and dothiepin.
    Moon CA; Chapman JP; Healey JC; Hannington JA
    Curr Med Res Opin; 1990; 12(1):34-42. PubMed ID: 2188795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
    Cohn CK; Shrivastava R; Mendels J; Cohn JB; Fabre LF; Claghorn JL; Dessain EC; Itil TM; Lautin A
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():28-33. PubMed ID: 2258379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
    Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U
    Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
    Mahapatra SN; Hackett D
    Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
    Mullin JM; Pandita-Gunawardena VR; Whitehead AM
    Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
    [No Abstract]   [Full Text] [Related]  

  • 30. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
    Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of clinical use of sertraline by family practice physicians in a small Air Force hospital.
    Bourgeois JA
    Mil Med; 1996 Jul; 161(7):425-7. PubMed ID: 8754718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF
    Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sertraline in the treatment of mixed anxiety and depression disorder].
    Carrasco JL; Díaz-Marsá M; Sáiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(3):141-5. PubMed ID: 9381956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.
    Ferguson JM; Mendels J; Manowitz NR
    J Clin Psychiatry; 1994 Jun; 55(6):258-63. PubMed ID: 8071282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.
    Scott TF; Nussbaum P; McConnell H; Brill P
    Neurol Res; 1995 Dec; 17(6):421-2. PubMed ID: 8622794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report on a double-blind comparison of two different regimens of dothiepin (prothiaden).
    Boening J
    J Int Med Res; 1983; 11(1):15-20. PubMed ID: 6832463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of sertraline-induced stuttering.
    Christensen RC; Byerly MJ; McElroy RA
    J Clin Psychopharmacol; 1996 Feb; 16(1):92-3. PubMed ID: 8834434
    [No Abstract]   [Full Text] [Related]  

  • 40. Toleration and safety of sertraline: experience worldwide.
    Doogan DP
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():47-56. PubMed ID: 1806630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.